Single Dose Mass Balance Study With [14C]Iruplinalkib (WX-0593) In Healthy Male Volunteers
Clinical trial NCT05716126 · COMPLETED
Trial details
- NCT number
- NCT05716126
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-15
- Primary completion
- 2020-12-15
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.